Mary Chebib

6.4k citations
146 papers · 5.0k indexed · h-index 41

Mary Chebib

146 papers receiving 4.9k citations

Peers

Mary Chebib
Comparison fields: 5 of 124
  • Molecular Biology 2.4k
  • Cellular and Molecular Neuroscience 2.2k
  • Pharmacology 745
  • Organic Chemistry 653
  • Complementary and alternative medicine 574
Replace Hyewhon Rhim with:
Hyewhon Rhim South Korea
Maribel Antonello Rubin Brazil
Makoto Naoi Japan
Wakako Maruyama Japan
Pamela S. Puttfarcken United States
Carlos Fernando Mello Brazil
E. Sofić Bosnia and Herzegovina
Toshiaki Kume Japan
Yutaka Sagara United States
Fiorella Casamenti Italy
Mary Chebib relative to Hyewhon Rhim South Korea Hyewhon Rhim's profile →
Citations per field
00.5×1.5×
Hyewhon Rhim · 1×
Citations per year

Countries citing papers authored by Mary Chebib

Since Specialization
Citations

This map shows the geographic impact of Mary Chebib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Chebib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Chebib more than expected).

Fields of papers citing papers by Mary Chebib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Chebib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Chebib. The network helps show where Mary Chebib may publish in the future.

Co-authorship network of co-authors of Mary Chebib

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Chebib. A scholar is included among the top collaborators of Mary Chebib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Chebib. Mary Chebib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 10
3 11
4 11
5 13
6 37
7 32
8 11
9 62
10 11
11 21
12 8
13 25
14 96
15 33
16 10
17 73
18 52
19 18
20 14

About Mary Chebib

Mary Chebib is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Complementary and alternative medicine, having authored 146 papers that have together received 5.0k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (88 papers), Nicotinic Acetylcholine Receptors Study (79 papers) and Ion channel regulation and function (25 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.2k citations), Biological Psychiatry (182 citations) and Complementary and alternative medicine (574 citations). Mary Chebib has collaborated with scholars based in Australia, Denmark and United States. Frequent co-authors include Graham A.R. Johnston, Jane R. Hanrahan, Nathan L. Absalom, Kenneth N. Mewett, Han Chow Chua, Rujee K. Duke, Nasiara Karim, Iain S. McGregor, Jonathon C. Arnold and Philip K. Ahring. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026